REGULATION OF ALVEOLAR EPITHELIAL PHENOTYPIC EXPRESSION
肺泡上皮表型表达的调节
基本信息
- 批准号:6609135
- 负责人:
- 金额:$ 8.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2002
- 资助国家:美国
- 起止时间:2002-07-08 至 2003-06-30
- 项目状态:已结题
- 来源:
- 关键词:biological signal transduction biomarker developmental genetics gene expression genetic markers genetic regulatory element genetic transcription genetically modified animals histogenesis laboratory mouse laboratory rat lung alveolus lung development respiratory epithelium tissue /cell culture transcription factor
项目摘要
The alveolar epithelium is comprised of two morphologically distinct differentiated epithelial cells, type I and type II cells, both of which are thought to be critical for normal lung function. Although the establishment and maintenance of a normal alveolar epithelium is essential for mammalian life, factors controlling the expression of cellular phenotype are not well understood. In general, the regulation of phenotypic expression involves both activation and expression of gene transcription. Lack of suitable cell culture models or unique cell-specific biochemical markers has made it difficult to study regulation of phenotypic expression in the lung. In recent years, considerable progress has been made in the development of appropriate markers and in vitro systems. The experiments describes in this project concern the regulation of phenotypic expression of the alveolar epithelium, focusing on the expression of type I and type II cell phenotype- specific markers, both in vitro and in vivo. Recent observations, documented in previous publications and in the Progress Reports to Projects 3 and 4, suggest that mechanical factors play an important role in regulating alveolar epithelial phenotypic expression. The broad objectives of this proposal are two-fold: 1) to define the regulatory elements that dictate organ and cell- specificity for RTI40, which, within the lung, is a specific marker for type I cells; and 2) to define the mechanisms by which mechanical factors modulate cell phenotypic expression in vitro. SPECIFIC AIMS 1. To determine the regions of the RT140 gene that direct tissue and cell- specific expression. 2. To determine the cis-acting elements and trans-acting factors responsible for regulating expression of RTI40. 3. To elucidate the elements responsible for mechanosensitive regulation of transcription of SP-C and RT140. 4. To identify some of the signaling pathways most likely to be involved in mechanical transduction of events in type I and type II cells.
肺泡上皮由两种形态上不同的分化上皮细胞组成,I型和II型细胞,这两种细胞都被认为是正常肺功能的关键。虽然正常肺泡上皮细胞的建立和维持对哺乳动物的生命是必不可少的,但控制细胞表型表达的因素还不清楚。通常,表型表达的调节涉及基因转录的激活和表达。由于缺乏合适的细胞培养模型或独特的细胞特异性生化标记物,很难研究肺中表型表达的调控。近年来,在开发适当的标记物和体外系统方面取得了相当大的进展。该项目中描述的实验涉及肺泡上皮细胞表型表达的调节,重点是体外和体内I型和II型细胞表型特异性标志物的表达。最近的观察,记录在以前的出版物和项目3和4的进展报告中,表明机械因素在调节肺泡上皮细胞表型表达中起着重要作用。该提议的广泛目标是双重的:1)定义决定RTI 40的器官和细胞特异性的调节元件,RTI 40在肺内是I型细胞的特异性标志物;和2)定义机械因子在体外调节细胞表型表达的机制。具体目标1.确定RT 140基因指导组织和细胞特异性表达的区域。2.确定RTI 40表达调控的顺式作用元件和反式作用因子。3.阐明SP-C和RT 140的机械敏感性转录调控元件。4.确定最可能参与I型和II型细胞中事件机械转导的一些信号通路。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LELAND George DOBBS其他文献
LELAND George DOBBS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LELAND George DOBBS', 18)}}的其他基金
ALVEOLAR EPITHELIAL CELL FATES: MAPPING AND REGULATION
肺泡上皮细胞命运:定位和调节
- 批准号:
8054535 - 财政年份:2011
- 资助金额:
$ 8.86万 - 项目类别:
Novel reagents for alveolar type I and type II cells
用于肺泡 I 型和 II 型细胞的新型试剂
- 批准号:
7819878 - 财政年份:2009
- 资助金额:
$ 8.86万 - 项目类别:
Novel reagents for alveolar type I and type II cells
用于肺泡 I 型和 II 型细胞的新型试剂
- 批准号:
7935330 - 财政年份:2009
- 资助金额:
$ 8.86万 - 项目类别:
REGULATION OF ALVEOLAR EPITHELIAL PHENOTYPIC EXPRESSION
肺泡上皮表型表达的调节
- 批准号:
6501907 - 财政年份:2001
- 资助金额:
$ 8.86万 - 项目类别:
REGULATION OF ALVEOLAR EPITHELIAL PHENOTYPIC EXPRESSION
肺泡上皮表型表达的调节
- 批准号:
6324730 - 财政年份:2000
- 资助金额:
$ 8.86万 - 项目类别:
REGULATION OF ALVEOLAR EPITHELIAL PHENOTYPIC EXPRESSION
肺泡上皮表型表达的调节
- 批准号:
6199968 - 财政年份:1999
- 资助金额:
$ 8.86万 - 项目类别:
REGULATION OF ALVEOLAR EPITHELIAL PHENOTYPIC EXPRESSION
肺泡上皮表型表达的调节
- 批准号:
6109549 - 财政年份:1998
- 资助金额:
$ 8.86万 - 项目类别:
相似国自然基金
基于DNA甲基化交互网络的癌症hallmark挖掘及其在癌症转移biomarker筛选中的应用
- 批准号:61602201
- 批准年份:2016
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
血清miRNAs成为一种新的biomarker在PD诊断中的价值和LRRK2基因调控的机制研究
- 批准号:81170309
- 批准年份:2011
- 资助金额:50.0 万元
- 项目类别:面上项目
非小细胞肺癌Biomarker的Imaging MS研究新方法
- 批准号:30672394
- 批准年份:2006
- 资助金额:30.0 万元
- 项目类别:面上项目
相似海外基金
酸化ストレス応答アポトーシス誘導蛋白のUCに対する新規Biomarker探索と治療への展開
寻找治疗 UC 的氧化应激反应性凋亡诱导蛋白的新生物标志物并开发治疗方法
- 批准号:
24K11919 - 财政年份:2024
- 资助金额:
$ 8.86万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
肝内胆管癌新規Biomarkerの同定及び癌周囲間質を標的とした新規治療開発
鉴定肝内胆管癌的新型生物标志物并开发针对癌周基质的新疗法
- 批准号:
24K19350 - 财政年份:2024
- 资助金额:
$ 8.86万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
収縮能が保たれた心不全の機械学習分類とmicroRNAなどのbiomarkerの探索
机器学习对具有保留收缩性的心力衰竭进行分类并搜索 microRNA 等生物标志物
- 批准号:
24K19007 - 财政年份:2024
- 资助金额:
$ 8.86万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of a predictive biomarker for Parkinson's disease
帕金森病预测生物标志物的开发
- 批准号:
MR/Y019415/1 - 财政年份:2024
- 资助金额:
$ 8.86万 - 项目类别:
Research Grant
Sleep and circadian dysfunction in ageing and neurodegeneration: a life course and biomarker study of the British 1946 birth cohort.
衰老和神经退行性疾病中的睡眠和昼夜节律功能障碍:对英国 1946 年出生队列的生命历程和生物标志物研究。
- 批准号:
MR/Y009452/1 - 财政年份:2024
- 资助金额:
$ 8.86万 - 项目类别:
Fellowship
Biomarker-Based Platform for Early Diagnosis of Chronic Liver Disease to Enable Personalized Therapy (LIVERAIM)
基于生物标志物的慢性肝病早期诊断平台,以实现个性化治疗(LIVERAIM)
- 批准号:
10087822 - 财政年份:2024
- 资助金额:
$ 8.86万 - 项目类别:
EU-Funded
Enhanced stratification of COPD patients via integration of a digitally enabled biomarker Point-of-Care test within a Remote Patient Monitoring tool
通过在远程患者监测工具中集成数字化生物标志物即时检测,增强 COPD 患者的分层
- 批准号:
10098600 - 财政年份:2024
- 资助金额:
$ 8.86万 - 项目类别:
Collaborative R&D
QuBIE: Quantitative Biomarker Identification for Non-Endoscopic Prediction and Monitoring of Treatment Response in Eosinophilic Oesophagitis
QuBIE:用于非内镜预测和监测嗜酸性食管炎治疗反应的定量生物标志物鉴定
- 批准号:
10083253 - 财政年份:2024
- 资助金额:
$ 8.86万 - 项目类别:
Collaborative R&D
膵癌腫瘍内線維化に着目した術前化学療法効果予測に関する画像biomarkerの確立
建立预测胰腺癌瘤内纤维化术前化疗效果的影像生物标志物
- 批准号:
24K18824 - 财政年份:2024
- 资助金额:
$ 8.86万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Multi-modal non-invasive biomarker screening for high-risk undiagnosed liver disease
针对高危未确诊肝病的多模式非侵入性生物标志物筛查
- 批准号:
10073169 - 财政年份:2023
- 资助金额:
$ 8.86万 - 项目类别:
Collaborative R&D